LH
Laboratory Corporation of America Holdings
NYSE: LH · HEALTHCARE · DIAGNOSTICS & RESEARCH
$257.14
-0.94% today
Updated 2026-04-29
Market cap
$21.19B
P/E ratio
24.56
P/S ratio
1.52x
EPS (TTM)
$10.47
Dividend yield
1.11%
52W range
$237 – $292
Volume
0.6M
Laboratory Corporation of America Holdings (LH) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+3.1%
Last 4 quarters
Revenue YoY growth
+5.6%
Most recent quarter
EPS YoY growth
+18.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.4%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-1.2%
2025-10-23
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-05 | $4.07 | +3.3% | $276.16 | $277.20 | +0.4% |
| 2025-10-23 | $4.18 | +1.7% | $282.84 | $279.49 | -1.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $3.94 | $4.07 | +3.3% | $3.52B | +5.6% |
| 2025-09-30 | $4.11 | $4.18 | +1.7% | $3.56B | +8.6% |
| 2025-06-30 | $4.16 | $4.35 | +4.6% | $3.53B | +9.5% |
| 2025-03-31 | $3.73 | $3.84 | +2.9% | $3.35B | +5.3% |
| 2024-12-31 | $3.39 | $3.45 | +1.8% | $3.33B | +9.8% |
| 2024-09-30 | $3.49 | $3.50 | +0.3% | $3.28B | +7.4% |
| 2024-06-30 | $3.80 | $3.94 | +3.7% | $3.22B | +6.2% |
| 2024-03-31 | $3.48 | $3.68 | +5.7% | $3.18B | +4.6% |
| 2023-12-31 | $3.26 | $3.30 | +1.2% | $3.03B | — |
| 2023-09-30 | $3.33 | $3.38 | +1.5% | $3.06B | — |
| 2023-06-30 | $3.53 | $3.80 | +7.6% | $3.03B | — |
| 2023-03-31 | $3.96 | $3.82 | -3.5% | $3.04B | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $18.42 | $15.1B | +8.3% | 10 | high |
| 2027 (E) | $19.86 | $15.8B | +4.8% | 10 | high |
| 2028 (E) | $21.24 | $16.4B | +3.9% | 10 | medium |
| 2029 (E) | $22.68 | $17.1B | +3.9% | 10 | medium |
| 2030 (E) | $24.21 | $17.8B | +4.0% | 10 | medium |
Frequently asked questions
Has Laboratory Corporation of America Holdings beaten earnings estimates?
Laboratory Corporation of America Holdings has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +3.1% over the last 4 quarters.
How does LH stock react to earnings?
LH stock has moved an average of -0.4% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Laboratory Corporation of America Holdings's revenue growth rate?
Laboratory Corporation of America Holdings reported year-over-year revenue growth of +5.6% in its most recent quarter, with EPS growing +18.0% year-over-year.
What is the expected EPS for LH in 2026?
Analysts expect Laboratory Corporation of America Holdings to report EPS of $18.42 for fiscal year 2026, on revenue of $15.1B, based on estimates from 10 analysts.